Dr. Bylow is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9200 W Wisconsin Ave
# Neoplast
Milwaukee, WI 53226Phone+1 414-805-4600Fax+1 414-805-6808
Education & Training
University of ChicagoFellowship, Hematology and Medical Oncology, 2004 - 2007
Vanderbilt University Medical CenterResidency, Internal Medicine, 2000 - 2003
University of Wisconsin School of Medicine & Public HealthClass of 2000
Certifications & Licensure
WI State Medical License 2007 - 2025
IL State Medical License 2003 - 2008
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer Start of enrollment: 2009 Jul 15
- BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma Start of enrollment: 2010 Jan 01
- Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer Who Have No Evidence of Disease After Surgery Start of enrollment: 2012 Aug 08
- Join now to see all
Publications & Presentations
PubMed
- 104 citationsFalls and physical performance deficits in older patients with prostate cancer undergoing androgen deprivation therapy.Kathryn A. Bylow, William Dale, Karen M. Mustian, Walter M. Stadler, Miriam B. Rodin
Urology. 2008-08-01 - 87 citationsDoes androgen-deprivation therapy accelerate the development of frailty in older men with prostate cancer?: a conceptual review.Kathryn A. Bylow, Supriya G. Mohile, Walter M. Stadler, William Dale
Cancer. 2007-12-15 - 83 citationsDouble-Blind, Randomized, Phase 2 Trial of Maintenance Sunitinib Versus Placebo After Response to Chemotherapy in Patients With Advanced Urothelial CarcinomaPetros Grivas, Stephanie Daignault, Scott T. Tagawa, David M. Nanus, Walter M. Stadler
Cancer. 2014-03-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
